Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Molecular Pharmaceutics
|
January 26, 2008
Nonribosomal peptide synthetases involved in the production of medically relevant natural products
Elizabeth A Felnagle, Emily E Jackson, Yolande A Chan, et al.
Antimicrobial Agents and Chemotherapy
|
November 18, 2025
Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates
Callan R Bleick, Sean R Van Helden, Andrew D Berti, et al.
Antimicrobial Agents and Chemotherapy
|
January 15, 2020
Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus with Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis
Christopher R Miller, Somrita Dey, Paula D Smolenski, et al.
Microbiology Spectrum
|
October 29, 2024
It takes two to tango: Preserving daptomycin efficacy against daptomycin-resistant MRSA using daptomycin-phage co-therapy
Casey L Madison, Anja S J Steinert, Corrin E Luedeke, et al.
Antibiotics (Basel, Switzerland)
|
December 22, 2019
Reduced Production of Bacterial Membrane Vesicles Predicts Mortality in ST45/USA600 Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia
Somrita Dey, Smitha Gudipati, Christopher Giuliano, et al.
Antimicrobial Agents and Chemotherapy
|
November 4, 2015
Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam-Daptomycin Synergy
Andrew D Berti, Erin Theisen, John-Demian Sauer, et al.
Current Drug Safety
|
March 18, 2022
Clinical Outcomes of Zinc Supplementation Among COVID-19 Patients
Andrew D Berti, Pramodini B Kale-Pradhan, Christopher A Giuliano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2017
Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia
Warren E Rose, Sanjay K Shukla, Andrew D Berti, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 2020
Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin
Rachel E Jenson, Sarah L Baines, Benjamin P Howden, et al.
The Journal of Antimicrobial Chemotherapy
|
May 3, 2018
Daptomycin selects for genetic and phenotypic adaptations leading to antibiotic tolerance in MRSA
Andrew D Berti, Neehal Shukla, Aaron D Rottier, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Molecular Pharmaceutics
|
January 26, 2008
Nonribosomal peptide synthetases involved in the production of medically relevant natural products
Elizabeth A Felnagle, Emily E Jackson, Yolande A Chan, et al.
Antimicrobial Agents and Chemotherapy
|
November 18, 2025
Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates
Callan R Bleick, Sean R Van Helden, Andrew D Berti, et al.
Antimicrobial Agents and Chemotherapy
|
January 15, 2020
Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus with Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis
Christopher R Miller, Somrita Dey, Paula D Smolenski, et al.
Microbiology Spectrum
|
October 29, 2024
It takes two to tango: Preserving daptomycin efficacy against daptomycin-resistant MRSA using daptomycin-phage co-therapy
Casey L Madison, Anja S J Steinert, Corrin E Luedeke, et al.
Antibiotics (Basel, Switzerland)
|
December 22, 2019
Reduced Production of Bacterial Membrane Vesicles Predicts Mortality in ST45/USA600 Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia
Somrita Dey, Smitha Gudipati, Christopher Giuliano, et al.
Antimicrobial Agents and Chemotherapy
|
November 4, 2015
Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam-Daptomycin Synergy
Andrew D Berti, Erin Theisen, John-Demian Sauer, et al.
Current Drug Safety
|
March 18, 2022
Clinical Outcomes of Zinc Supplementation Among COVID-19 Patients
Andrew D Berti, Pramodini B Kale-Pradhan, Christopher A Giuliano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2017
Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia
Warren E Rose, Sanjay K Shukla, Andrew D Berti, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 2020
Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin
Rachel E Jenson, Sarah L Baines, Benjamin P Howden, et al.
The Journal of Antimicrobial Chemotherapy
|
May 3, 2018
Daptomycin selects for genetic and phenotypic adaptations leading to antibiotic tolerance in MRSA
Andrew D Berti, Neehal Shukla, Aaron D Rottier, et al.
Page
of 4